Ardsley Advisory Partners LP Aclaris Therapeutics, Inc. Transaction History

Ardsley Advisory Partners LP

  • $564 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$16.46 - $20.33 $329,200 - $406,599
-20,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$17.08 - $25.64 $341,599 - $512,800
20,000 New
20,000 $350,000
Q4 2017

Feb 14, 2018
SELL
$21.47 - $27.8 $429,400 - $556,000
-20,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$23.02 - $28.8 $115,100 - $144,000
5,000 Added 33.33%
20,000 $516,000
Q2 2017

Sep 21, 2017
BUY
N/A
15,000
15,000 $407,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $271M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email